Abdelrahman Elshafay

Abdelrahman Elshafay

Auto-generated profile, based on publicly available information

Abdelrahman Elshafay

Faculty of Medicine, Al-Azhar University, Cairo, 11884, Egypt

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Respiratory Medicine
Verified
Journal Article
Closed access
NVNguyen Lam Vuong
Nguyen Lam Vuong
AEAbdelrahman Elshafay
Abdelrahman Elshafay
LTLe Phuong Thao
Le Phuong Thao
AAAhmed Ramadan Abdalla
Ahmed Ramadan Abdalla
IMIslam Ashraf Mohyeldin
Islam Ashraf Mohyeldin
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy

24 April 2018 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
MMMostafa Ebraheem Morra
Mostafa Ebraheem Morra
AAAhmed M.A. Altibi
Ahmed M.A. Altibi
SISomia Iqtadar
Somia Iqtadar
Minh H. N. LeMinh H. N. Le
Minh H. N. Le
SESameh Samir Elawady
Sameh Samir Elawady
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy
1

17 November 2017 in PeerJ
Verified
Journal Article
Open access
PDF file
AEAbdelrahman Elshafay
Abdelrahman Elshafay
NTNgo Xuan Tinh
Ngo Xuan Tinh
SSSamar Salman
Samar Salman
YSYara Saber Shaheen
Yara Saber Shaheen
EOEman Bashir Othman
Eman Bashir Othman
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy
Ginsenoside Rk1 (G-Rk1) is a unique component created by processing the ginseng plant (mainly Sung Ginseng (SG)) at high temperatures. The aim of our study was to systematically review the pharmacological effects of G-Rk1. We utilized and manually searched eight databases to selectin vivoandin vitrooriginal studies that provided information about biological, pharmaceutical effects of G-Rk1 and were published up to July 2017 with no restriction on language or study design. Out of the 156 papers identified, we retrieved 28 eligible papers in the first skimming phase of research. Several articles largely described the G-Rk1 anti-cancer activity investigating “cell viability”, “cell proliferation inhibition”, “apoptotic activity”, and “effects of G-Rk1 on G1 phase and autophagy in tumor cells” either alone or in combination with G-Rg5. Others proved that it has antiplatelet aggregation activities, anti-inflammatory effects, anti-insulin resistance, nephroprotective effect, antimicrobial effect, cognitive function enhancement, lipid accumulation reduction and prevents osteoporosis. In conclusion, G-Rk1 has a significant anti-tumor effect on liver cancer, melanoma, lung cancer, cervical cancer, colon cancer, pancreatic cancer, gastric cancer, and breast adenocarcinoma againstin vitrocell lines.In vivoexperiments are further warranted to confirm these effects.

22 February 2019 in CNS Drugs
Verified
Journal Article
Closed access
PDF file
AEAbdelrahman Elshafay
Abdelrahman Elshafay
THTruong Hong Hieu
Truong Hong Hieu
MDMohamed Fahmy Doheim
Mohamed Fahmy Doheim
MKMahmoud Attia Mohamed Kassem
Mahmoud Attia Mohamed Kassem
MEMohammed Fathi Eldoadoa
Mohammed Fathi Eldoadoa
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy

28 June 2017 in American Journal of Cardiovascular Drugs
Verified
Journal Article
Closed access
PDF file
AEAbdelrahman Elshafay
Abdelrahman Elshafay
DTDuy Hieu Truong
Duy Hieu Truong
MAMohamed M. AboElnas
Mohamed M. AboElnas
HIHossam Idrees
Hossam Idrees
HMHatem G. Metwali
Hatem G. Metwali
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy

9 June 2017 in PeerJ Preprints
Verified
Preprint
Open access
PDF file
AEAbdelrahman Elshafay
Abdelrahman Elshafay
NTNgo Xuan Tinh
Ngo Xuan Tinh
SSSamar Salman
Samar Salman
YSYara Saber Shaheen
Yara Saber Shaheen
EOEman Bashir Othman
Eman Bashir Othman
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy
Ginsenoside Rk1 (G-Rk1) is one of the unique components created by processing ginseng at high temperature, in particular of Sun Ginseng (SG). The aim of our study was to systematically review the pharmacological effects of G-Rk1.we conducted our search in eight databases and searched manually to select in vivo and in vitro original studies that provided information about biological pharmaceutical effects of G-Rk1 and were published up to August 2015 with no restriction in language or study design. We retrieved 21 eligible papers out of 121 identified ones. Some studies confirmed the G-Rk1 anticancer effects by investigating “cell viability”, “cell proliferation inhibition”, “apoptotic activity”, “anticancer activity” and “effects of G-Rk1 on G1 phase and autophagy in tumor cells” either alone or in combination with G-Rg5. Others proved that it has anti-platelet aggregation activities and anti-inflammatory effects, enhances cognitive function, reduces lipid accumulation and prevents osteoporosis. In conclusion, G-Rk1 has a significant anti-tumor effect of liver cancer, melanoma, and gastric cancer. Additionally, G-Rk1 has demonstrated as anti-platelet aggregation, anti-inflammatory, and anti-lipid accumulation. All these results corroborate the clinical effects of G-Rk1 and demonstrate the potential possibility to develop G-Rk1-based treatments, either alone or in combination with G-Rg5, with previously mentioned conditions.